|
|
|
|
Spotlight on HIV/AIDS: Barriers still keep thousands from HIV care and treatment
(ARA) - Today, almost three decades into the HIV/AIDS epidemic, there are 1.1 million people currently living with HIV in the United States.While strides have been made in the fight against this disease, there are an estimated 640,000 people with ...
|
|
|
HIV Alliance Offers Free Rapid HIV Testing For People of Color
EUGENE, Ore--The most recent statistics from the Centers for Disease Control and Prevention report 1.1 million Americans are infected with HIV/AIDS.The HIV Alliance and the University of Oregon's Black Student Union are teaming up to offer free HIV...
|
|
|
Prezista Now Approved as Part of Combination Therapy for Pediatric Patients Six Years of Age and Older with HI
PREZISTA* Now Approved as Part of Combination Therapy for Pediatric Patients Six Years of Age and Older with HIV Approval based on DELPHI study that demonstrated 74 per cent of pediatric patients taking PREZISTA in combination with other antiretrovirals...
|
|
|
Targeting Hidden HIV: Research Group Licenses New Prostratin Technology
Los Angeles-based AIDS Research Alliance (ARA) has been granted exclusive rights to novel technology that will allow researchers to synthesize prostratin, a natural compound believed to target HIV hiding in inactive CD4 cells in the body, according...
|
|
|
In Kenya, UN partners with MTV to dramatize stories of love - and HIV infection
In Kenya, UN partners with MTV to dramatize stories of love and HIV infection 9 February 2010 The United Nations and MTV are reaching out to young Kenyans to highlight that HIV is not a death sentence though a new three-part television series...
|
|
|
In Country, UN Partners with MTV to Dramatize Stories of Love and HIV Infection
The United Nations and MTV are reaching out young Kenyans to highlight that HIV is not a death sentence though a new three-part television series exploring the lives and love of a group of friends in Nairobi.'It's fast, it's furious, it's cool - and...
|
|
|
AIDS tests for suspects
RAPE VICTIMS who have been attacked by a person with AIDS can avoid becoming infected themselves by beginning a drug treatment within 72 hours of the assault.Many victims start the treatment even without knowing whether their attacker was HIV...
|
|
|
Gilead Quad Pill Can Overtake Atripla, Milligan Says (Update1)
9 (Bloomberg) -- Gilead Sciences Inc., the worlds biggest maker of AIDS medicines, will begin three final-stage tests in 2010 for a four-drug combination pill against HIV that has the potential to generate $4 billion a year.The quad can overtake...
|
|
|
No headway on HIV vaccine after 20 years
Pune: Global efforts over the last two decades to produce an HIV vaccine have made little headway.Heres why: Vaccine trials on monkeys and chimpanzees have routinely failed to elicit a satisfactory immune response against the human immuno-deficiency...
|
|
|
Lack of resources threaten gains in Pakistan's HIV response, warns UN agency
Although Pakistan has a plan of action to tackle HIV and AIDS, the country is facing a lack of resources that could jeopardize an effective and timely response to the epidemic, according to the lead United Nations agency on the issue.Pakistan has...
|
|
|
Racial Disparities in Perinatal HIV Infections Decline Slightly
MONDAY, Feb.8 (HealthDay News) -- Racial disparities in perinatal HIV diagnoses have declined in recent years, although African-Americans and Hispanics still account for the majority of infections, according to research published in the Feb. 5 issue...
|
|
|
AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University
License will accelerate the development of prostratin??the first in a new class of drugs for the treatment of HIV/AIDS.(PRWEB) February 8, 2010 --AIDS Research Alliance announced today the signing of a new licensing agreement with Stanford University,...
|
|
|
Global Update: H.I.V. and Herpes: Treating Herpes Doesnt Reduce Chance That AIDS Virus Will Spread, Study Finds
Treating herpes in people who are also infected with H.I.V.does not reduce the chances that they will pass on the AIDS virus, according to a new study. Health Guide: HIV Infection | Herpes Simplex | Genital Herpes The results were a...
|
|
|
Cardinal Vidal urges public not to generalize call center agents as AIDS high-risk group
CEBU CITY.8 Cebu Archbishop Ricardo Cardinal Vidal urged the public not to generalize all call center agents as at risk of AIDS and other diseases. Vidal, however, suggested that call center companies should give their workers more time to rest,...
|
|
|
B.C. to Seek and Treat Most Vulnerable HIV Patients
- A unique pilot program will get underway shortly in Vancouvers Downtown Eastside and Prince George to seek and treat vulnerable populations who are either undiagnosed or untreated for HIV.The four-year, $48-million pilot called Seek and Treat is the...
|
|
|
Congressmen, Citing Reports Of Fraud, Seek Accounting For AIDS Funding
News Archive [link] Web Wikipedia Medical Dictionary [link] Follow us on: Personalization login | register HIV / AIDS News Main Category: HIV / AIDS Also Included In: Public Health Article Date: 08 Feb 2010 - 1:00 PST email to a friend...
|
|
|
Africa: US freezes HIV spending
Kampala - A US decision to freeze spending on treatment for HIV in several African countries has prompted concern that some of the gains made against the Aids epidemic since 2003 could be reversed.President George W Bush's Emergency Plan for ...
|
|
|
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero
"In contrast, we hypothesized that NVP resistance mutations would accumulate in HIV-infected infants in the NVP+ZDV arm after prophylaxis was stopped because NVP has longer half-life than ZDV.In this case, ZDV would be cleared before NVP, leaving the...
|
|
|
Scripps Research scientists find two compounds that lay the foundation for a new class of AIDS drug
Novel therapies could improve potency of existing AIDS treatments, help to combat drug-resistant virus strains 05 Feb 2010 - A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme...
|
|
|
Mice stave off HIV infection
The mice in J.Victor Garcia-Martinez's lab at UNC-Chapel Hill foretell a major new breakthrough in the fight against AIDS. Engineered to have human immune systems, healthy rodents have repeatedly been exposed to the virus that causes AIDS, but...
|
|
|
Merck Partners with BC Centre for Excellence in HIV/AIDS for Seek and Treat research program to reduce HIV/AID
- Merck is pleased to announce its $1.5 million funding commitment over three years to the BC Centre for Excellence in HIV/AIDS (BC-CfE) in support of its research program entitled 'Seek and Treat for Optimal Prevention of HIV/AIDS', known as the 'seek &...
|
|
|
US puts locals in charge of AIDS spending
Since 2004, the U.S.government has funded a project for AIDS patients in rural South Africa through Catholic Relief Services, the charity arm of the Catholic Church in the United States. In a significant shift made official this week, the U.S. will...
|
|
|
New class of anti-HIV drugs possible
La Jolla, Calif.-- U.S. scientists say they've discovered two compounds that might lay the foundation for the development of a new class of anti-HIV drugs. Scripps Research scientists said the compounds act on novel binding sites for an enzyme used...
|
|
|
New Class Of Anti-HIV Drugs Possible
scientists say they've discovered two compounds that might lay the foundation for the development of a new class of anti-HIV drugs.Scripps Research scientists said the compounds act on novel binding sites for an enzyme used by the human...
|
|
|
US Mission Campaigns Against Stigmatization Of HIV/AIDS Victims
The United States (US) Diplomatic Mission to Nigeria organized a two-day workshop to mark the day and to sensitize Nigerians about the pandemic at the Public Affairs Section of the US Consulate on Broad Street, Lagos and The Barack Obama American Corner at...
|
